Top Markets
#1 Smilek to the Bank Smilek to the Bank +50.56%
#2 Purr Purr +47.43%
#3 Pons Pons +45.47%
#4 Non-Playable Coin Non-Playable Coin +27.80%
#5 StonkBroker StonkBroker +27.01%
#6 ApeX ApeX +25.69%
#7 Kinetiq Kinetiq +25.58%
#8 Pudgy Penguins Pudgy Penguins +21.53%
#9 OriginTrail OriginTrail +19.79%
#10 Grass Grass +19.50%
Coin of the day
Smilek to the Bank Smilek to the Bank
Настройки
Язык
Pусский
Валюта
USD
Тема
Coya Therapeutics, Inc. Coya Therapeutics, Inc.

Coya Therapeutics, Inc.

COYA
Ранг среди акций #21166
Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on... Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and personalized autologous Treg cell therapies. Among its lead candidates is COYA 101, an autologous regulatory T-cell product that has successfully completed Phase 2a clinical trials for treating Amyotrophic Lateral Sclerosis (ALS). Moving towards Investigational New Drug (IND) applications are two key candidates: COYA 301 and COYA 302. COYA 301 is a Treg-enhancing biologic aimed at treating Frontotemporal Dementia. Meanwhile, COYA 302 is a dual-action biologic combination, suitable for subcutaneous or intravenous delivery, engineered to not only boost Treg function but also to diminish harmful T effector cell activity and activated macrophages in neurodegenerative and autoimmune disorders. Additionally, Coya has earlier-stage programs, including COYA 201, an allogeneic (off-the-shelf) Treg exosome candidate in preclinical development for a range of neurodegenerative, autoimmune, and metabolic conditions. Its pipeline also features COYA 206, an antigen-directed Treg-derived exosome product, currently in the discovery phase. Established in 2020, Coya Therapeutics maintains its headquarters in Houston, Texas.
Цена акции
$4.83
Последняя синхронизация: 2026-08-21
Рыночная капитализация
$113.30M
Изменение (1 день)
-0.62%
Изменение (1 год)
-29.59%
Страна
US
Торговля Coya Therapeutics, Inc. (COYA)

Категория

Healthcare
История дивидендов Coya Therapeutics, Inc. (COYA)
Coya Therapeutics, Inc. (тикер: COYA) выплатила в общей сложности 0 дивидендов.
Общая сумма всех дивидендов (с учетом дроблений акций): 0.00
Дивидендная доходность (TTM): 0
Дивидендные выплаты по Coya Therapeutics, Inc. (COYA) с 2026 по 2026
Годовые дивидендные выплаты
Год Дивиденды (с учетом дробления акций) Изменить
Недостаточно данных для указанных дат.
Список всех дивидендных выплат
Год Дивиденд Изменить
Недостаточно данных для указанных дат.
Дивиденды аналогичных компаний или конкурентов
Компания Количество дивидендных выплат Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH